ABNORMALITY OF THE BREAST, HP:0000769

Associated diseases: ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY, HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA, FRASER SYNDROME, ALSTROM SYNDROME, PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY, ?CHARGE SYNDROME, CHARGE SYNDROME, NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, FOCAL DERMAL HYPOPLASIA, CHIME SYNDROME, ENDOCRINE-CEREBROOSTEODYSPLASIA, OBESITY, MORBID, DUE TO LEPTIN DEFICIENCY, PRIMROSE SYNDROME, ACROMEGALY, SOMATIC, PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, ADAMS-OLIVER SYNDROME ADAMS-OLIVER SYNDROME 1, ANDROGEN INSENSITIVITY, PARTIAL, WITH OR WITHOUT BREAST CANCER, GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME, MEIER-GORLIN SYNDROME 1, NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA, MUCOLIPIDOSIS II ALPHA/BETA, ?HYPERPROLACTINEMIA, KABUKI SYNDROME 2, SCALP-EAR-NIPPLE SYNDROME, PETERS-PLUS SYNDROME, MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE, CARPENTER SYNDROME 2, CEREBRO-OCULO-FACIO-SKELETAL SYNDROME, PSEUDOHERMAPHRODITISM, MALE, WITH GYNECOMASTIA, ADULT SYNDROME, OVARIAN CARCINOMA, SOMATIC,; OVARIAN CANCER, SOMATIC,; ADENOCARCINOMA, OVARIAN, SOMATIC,; {OVARIAN CANCER, SOMATIC},; OVARIAN CARCINOMA, BOHRING-OPITZ SYNDROME, {BREAST-OVARIAN CANCER, FAMILIAL, 2}, HYPOGONADOTROPIC HYPOGONADISM 23 WITH OR WITHOUT ANOSMIA, MENTAL RETARDATION, AUTOSOMAL DOMINANT 17, COWDEN SYNDROME 2, INCONTINENTIA PIGMENTI, LEPRECHAUNISM, SPINAL AND BULBAR MUSCULAR ATROPHY OF KENNEDY, MOWAT-WILSON SYNDROME, MENTAL RETARDATION, AUTOSOMAL DOMINANT 34, CRANIOFRONTONASAL DYSPLASIA, ?MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3, PEUTZ-JEGHERS SYNDROME, ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE, YUNIS-VARON SYNDROME, SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2, MARTSOLF SYNDROME, LIMB-MAMMARY SYNDROME, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA, KOOLEN-DE VRIES SYNDROME, BORJESON-FORSSMAN-LEHMANN SYNDROME, MENTAL RETARDATION, X-LINKED, SYNDROMIC 15 (CABEZAS TYPE), JOHANSON-BLIZZARD SYNDROME, BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS, TYPE 1, BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS, TYPE 2, ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ, METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE, AROMATASE EXCESS SYNDROME, ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3, SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP, HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, WEAVER SYNDROME, HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA, MILLER SYNDROME, SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME, NOONAN SYNDROME 4, SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS, GAPO SYNDROME, ?BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2, SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1, LI-FRAUMENI SYNDROME, BANNAYAN-RILEY-RUVALCABA SYNDROME, MEIER-GORLIN SYNDROME 3, MENTAL RETARDATION, X-LINKED SYNDROMIC, NASCIMENTO-TYPE, POPLITEAL PTERYGIUM SYNDROME, BARTSOCAS-PAPAS TYPE, FAMILIAL ADENOMATOUS POLYPOSIS 3, COWDEN SYNDROME 1, LHERMITTE-DUCLOS SYNDROME, BREAST-OVARIAN CANCER, FAMILIAL 1, ?CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL, BREAST CANCER, SOMATIC, BREAST CANCER, EARLY-ONSET, {BREAST CANCER, PROTECTION AGAINST}, {BREAST CANCER, INVASIVE DUCTAL}, {BREAST CANCER, MALE, SUSCEPTIBILITY TO}, BREAST CANCER, {BREAST CANCER}, {BREAST CANCER, LOBULAR}, {?BREAST CANCER SUSCEPTIBILITY}, {BREAST CANCER, SUSCEPTIBILITY TO}, SYMMETRIC CIRCUMFERENTIAL SKIN CREASES, CONGENITAL, 2, MEIER-GORLIN SYNDROME 2, ABLEPHARON-MACROSTOMIA SYNDROME, COWDEN SYNDROME 6, CORNELIA DE LANGE SYNDROME 1, OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS, LI-FRAUMENI SYNDROME 2, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN, MEIER-GORLIN SYNDROME 4, SAETHRE-CHOTZEN SYNDROME, SAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES, ?ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME, BARBER-SAY SYNDROME, WILSON-TURNER SYNDROME, ANDROGEN INSENSITIVITY, ESCOBAR SYNDROME, BRANCHIOOCULOFACIAL SYNDROME, HAY-WELLS SYNDROME, MUIR-TORRE SYNDROME, COWDEN SYNDROME 5, MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3, ULNAR-MAMMARY SYNDROME, 3MC SYNDROME 1, SYMMETRIC CIRCUMFERENTIAL SKIN CREASES, CONGENITAL, 1, MARTIN-PROBST DEAFNESS-MENTAL RETARDATION SYNDROME, HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY, HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA (KALLMANN SYNDROME 1), CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME, ADENOMATOUS POLYPOSIS COLI, GARDNER SYNDROME, BRAIN TUMOR-POLYPOSIS SYNDROME 2, CPT II DEFICIENCY, LETHAL NEONATAL, 17,20-LYASE DEFICIENCY, ISOLATED, 17-ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, [AXILLARY ODOR, VARIATION IN], [EARWAX, WET/DRY], [COLOSTRUM SECRETION, VARIATION IN], SIALURIA, INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL, ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED, HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, AU-KLINE SYNDROME

Associated genes: BRCA2, KMT2A, CPT2, ACOX1, SEMA3E, IKBKG, PIK3CA, B3GLCT, SEPT9, LEP, CDH1, TSG101, ZEB2, STK11, ZBTB20, FAM175A, IBA57, ERCC6, GNPTAB, CDT1, NBN, SOS1, PIGL, ERCC2, GNE, CHRNG, CTNNB1, FIG4, WNT7A, GRIP1, FREM2, KRAS, NIPBL, FOXL2, TFAP2A, AR, ALMS1, ANOS1, GNAS, NOTCH1, GNRHR, PIGT, PPM1D, MLH1, FGFR1, EDA, SDHB, TAF6, ALG11, AKT2, POC1A, MEGF8, CBL, NTHL1, SLC25A46, HSD17B3, BCPR, ICK, RAD54L, RAD51, DHODH, KCTD1, ABCD4, TBX3, CYP21A2, TP63, PMM2, ARHGAP31, ORC4, GPC3, SETBP1, UBE2A, TWIST2, RAB3GAP2, OPCML, CUL4B, TMCO1, ORC6, UBR1, CHD7, TUBB, BRCA1, AKT1, RIPK4, KANSL1, AIP, SMS, PARK2, HDAC8, TP53, BRIP1, RB1CC1, HNRNPK, EZH2, TWIST1, KISS1R, XRCC3, EFNB1, PTEN, FGFR3, ANTXR1, AMER1, KDM6A, RBM28, HMMR, COX7B, ABCC11, CHST3, BARD1, LHB, CHEK2, ASXL1, CYP19A1, PHF6, RFT1, ATM, MAPRE2, RRAS2, CDKN2A, NQO2, PRLR, ORC1, INSR, MASP1, FRAS1, MSH2, FGFR2, PACS1, ITGA3, EDARADD, PHB, OFD1, RAB40AL, DPAGT1, APC, PTPRF, COL4A3BP, ATR, ESR1, CASP8, CYP17A1, KIF1BP, PORCN, PALB2, SLC22A18